Cerebral venous thrombosis in polycythemia rubra vera: a rare case report
DOI:
https://doi.org/10.18203/2349-3933.ijam20230373Keywords:
Polycythemia rubra vera, Cerebral venous thrombosis, Myeloproliferative disorder, ErythropoietinAbstract
Polycythemia rubra vera (PV) is a disease characterised by increased production of red blood cells due to genetic mutation which leads to increase in RBC mass and increased viscocity of blood. Myeloproliferative neoplasms have been implicated in the causation of cerebral venous thrombosis (CVT). Here we presented a 34 year old male who present with headache and diplopia. Fundus examination revealed bilateral papilledema. MRI brain with venogram was done which revealed right transverse and sigmoid sinus thrombosis. Blood investigations revealed polycythemia, elevated RBC counts and hematocrit levels. Peripheral smear showed increased RBC, WBC and platelets. Serum erythropoietin was low. Bone marrow aspiration study revealed hypercellular marrow. Patient tested positive for JAK2 V617F mutation. Patient was treated with anticoagulants, therapeutic phlebotomy and other supportive measures. Here we present a rare case of PV presenting with CVT.
References
Barbui T, Barosi G, Birgegard G, Cervantes F, Finazzi G, Griesshammer M, et al. Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European Leukemia Net. J Clin Oncol. 2011;29(6):761-70.
James C, Ugo V, Le Couédic JP, Staerk J, Delhommeau F, Lacout C, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 2005;434(7037):1144-8.
Spivak JL, Silver RT. The revised World Health Organization diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis: an alternative proposal. Blood. 2008;112(2):231-9.
Saposnik G, Barinagarrementeria F, Brown RD, Bushnell CD, Cucchiara B, Cushman M, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(4):1158-92.
Anía BJ, Suman VJ, Sobell JL, Codd MB, Silverstein MN, Melton LJ. Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989. Am J Hematol. 1994;47(2):89-93.
Berlin NI. Diagnosis and classification of the polycythemias. Semin Hematol. 1975;12(4):339-51.
Bhat V, Gs T, Rao SS, Sarma GRK, Deepalam SK. Clinical and Radiological Profile of Cerebrovascular Disease in Polycythemia: Analysis of Neurologic Manifestations from a Tertiary Center in South India. J Stroke Cerebrovasc Dis. 2022;31(1):106167.
Dentali F, Ageno W, Rumi E, Casetti I, Poli D, Scoditti U, et al. Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases. Thromb Res. 2014;134(1):41-3.
Zoraster RM, Rison RA. Acute embolic cerebral ischemia as an initial presentation of polycythemia vera: a case report. J Med Case Rep. 2013;7:131.
Bhat JSE, Kashyap. Smoker’s cerebral venous thrombosis-a retrospective study. Int J Contemp Med Res. 2016;3(10):2931-4.
